Complications of pelvic radiation in patients treated for gynecologic malignancies

Akila N. Viswanathan, Larissa J. Lee, Jairam R. Eswara, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Kristina L. Mirabeau-Beale, Brent S. Rose, Arvind G. Von Keudell, Jennifer Y. Wo

Research output: Contribution to journalReview article


Radiation therapy is a critical treatment modality in the management of patients with gynecologic tumors. New highly conformal external-beam and brachytherapy techniques have led to important reductions in recurrence and patient morbidity and mortality. However, patients who receive pelvic radiation for gynecologic malignancies may experience a unique constellation of toxicity because of the anatomic locations, combination with concurrent chemotherapy and/or surgery, as well as potential surgical interventions. Although side effects are often categorized into acute versus late toxicities, several late toxicities represent continuation and evolution of the same pathologic process. Comorbidities and radiation dose can significantly increase the risk of morbidity. Current understanding of the incidence of various morbidities in patients treated with current radiation techniques for gynecologic malignancies, the impact of chemotherapy and surgery, treatment options for those effects, and future areas of research are highlighted.

Original languageEnglish (US)
Pages (from-to)3870-3883
Number of pages14
Issue number24
StatePublished - Dec 1 2014
Externally publishedYes


  • Gynecologic cancer
  • Morbidity
  • Radiation
  • Toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Complications of pelvic radiation in patients treated for gynecologic malignancies'. Together they form a unique fingerprint.

  • Cite this

    Viswanathan, A. N., Lee, L. J., Eswara, J. R., Horowitz, N. S., Konstantinopoulos, P. A., Mirabeau-Beale, K. L., Rose, B. S., Von Keudell, A. G., & Wo, J. Y. (2014). Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer, 120(24), 3870-3883.